series-c-plus
Stage
4
Investors
About
Promethera Biosciences develops cell and gene therapies derived from the liver to treat severe liver diseases.
Explore Promethera Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.